Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether kava can aid tobacco cessation and alleviate stress and insomnia during abstinence; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kava (Piper methysticum)

Snippet

Sponsor: University of Florida | Conditions: Smoking | Phase 2 | Status: RECRUITING